Discover why ResMed is a top buy with strong fundamentals, robust cash flow, and dividend potential—ideal for recession-proof ...

The incoming AdvaMed chair talked about updates to Resmed’s products and how the company is handling competitive dynamics and ...

The first ASX 200 stock that could be a top buy is hearing implant leader Cochlear. It appears well position for growth over ...

Let's see why these shares could be great long term picks for Aussie investors. The post 2 screaming buy ASX shares I'd hold ...

The latest update on Wednesday morning shows ResMed shares down by 0.02%, trading at $246.16. At this price, Farrell's 11,442 ...

The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).

Air Voel, one of Canada’s leading providers of CPAP machines, masks, and sleep-health solutions, today announced the launch of its Sleep Better 2026 Initiative, a nationwide program designed to raise ...

In response to the update, the broker upgraded James Hardie shares to a buy rating with a $35.50 price target. Based on its ...

A fierce US$10 billion bidding war for the Nasdaq-listed anti-obesity drug maker Metsera has resulted in Pfizer emerging with the fat spoils.

Know about in Hindi on TheHealthSite.com, Explore with Articles, Photos, Video, न्यूज़, ताज़ा ख़बर in Hindi with TheHealthSite.com ...

A pioneering study, led by PFL Healthcare in collaboration with the University of Sheffield, has demonstrated that ...

The global Continuous Positive Airway Pressure (CPAP) market is positioned for notable growth over the forecast period from ...